Clinical Trial Update: Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chemotherapy plus immunotherapy with SBRT as neoadjuvant therapy for resectable non-small cell lung cancer; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: RECRUITING